CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Fleury SA Company Snapshot
Fleury SA operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fleury SA with three other pharmaceutical manufacturers in Latin America: Diagnosticos Da America SA (2016 sales of 3.04 billion Brazilian Reals [US$927.62 million] of which 100% was servi os auxiliares), Genomma Lab Internacional Sab De Cv of Mexico (11.32 billion Mexican Pesos [US$613.57 million] of which 59% was International), and Hypermarcas SA (3.29 billion Brazilian Reals [US$1.00 billion] ).

Sales Analysis. During the year ended December of 2016, sales at Fleury SA were 2.10 billion Brazilian Reals (US$639.44 million). This is an increase of 10.6% versus 2015, when the company's sales were 1.89 billion Brazilian Reals. This was the fifth consecutive year of sales increases at Fleury SA (and since 2011, sales have increased a total of 86%). Sales of Integrated Medicine saw an increase of 12.3% in 2016, from 309.42 million Brazilian Reals to 347.55 million Brazilian Reals.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Fleury SA
  Stock Performance Chart for Fleury SA
 
  Stock Data: Recent Stock Performance:
  Current Price (5/26/2017): 58.22
(Figures in Brazilian Reals)
1 Week 1.8%   13 Weeks 10.9%  
4 Weeks 34.4%   52 Weeks 119.7%  
 
Fleury SA Key Data:
  Ticker: FLRY3 Country: Brazil
  Exchanges: SOP Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2016 Sales 2,096,113,000
(Year Ending Jan 2017).
Employees: 8,400
  Currency: Brazilian Reals Market Cap: 9,147,242,578
  Fiscal Yr Ends: December Shares Outstanding: 157,115,125
  Share Type: Ordinary Closely Held Shares: 76,445,376
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.